| Human intestinal enteroids: a new model to study human rotavirus infection, host restriction, and pathophysiology K Saxena, SE Blutt, K Ettayebi, XL Zeng, JR Broughman, SE Crawford, ... Journal of virology 90 (1), 43-56, 2016 | 363 | 2016 |
| Human intestinal enteroids: new models to study gastrointestinal virus infections WY Zou, SE Blutt, SE Crawford, K Ettayebi, XL Zeng, K Saxena, S Ramani, ... Organoids: Stem Cells, Structure, and Function, 229-247, 2019 | 129 | 2019 |
| A paradox of transcriptional and functional innate interferon responses of human intestinal enteroids to enteric virus infection K Saxena, LM Simon, XL Zeng, SE Blutt, SE Crawford, NP Sastri, ... Proceedings of the National Academy of Sciences 114 (4), E570-E579, 2017 | 120 | 2017 |
| A phase 1b/2 study of azacitidine with PD‐L1 antibody avelumab in relapsed/refractory acute myeloid leukemia K Saxena, SM Herbrich, N Pemmaraju, TM Kadia, CD DiNardo, ... Cancer 127 (20), 3761-3771, 2021 | 43 | 2021 |
| Severe cutaneous human papillomavirus infection associated with natural killer cell deficiency following stem cell transplantation for severe combined immunodeficiency FO Seeborg, K Saxena, SK Nicholas, PP Banerjee, LS Angelo, EM Mace, ... Journal of allergy and clinical immunology 134 (6), 1451-1453. e1, 2014 | 32 | 2014 |
| Impact of frontline treatment approach on outcomes of myeloid blast phase CML K Saxena, E Jabbour, G Issa, K Sasaki, F Ravandi, A Maiti, N Daver, ... Journal of Hematology & Oncology 14, 1-10, 2021 | 26 | 2021 |
| An expert overview of emerging therapies for acute myeloid leukemia: novel small molecules targeting apoptosis, p53, transcriptional regulation and metabolism K Saxena, M Konopleva Expert Opinion on Investigational Drugs 29 (9), 973-988, 2020 | 12 | 2020 |
| New treatment options for older patients with acute myeloid leukemia K Saxena, M Konopleva Current treatment options in oncology 22 (5), 39, 2021 | 11 | 2021 |
| Harnessing apoptosis in AML K Saxena, C DiNardo, N Daver, M Konopleva Clinical Lymphoma Myeloma and Leukemia 20, S61-S64, 2020 | 7* | 2020 |
| Aza+ glutaminase inhibition with telaglenastat (Cb-839) for advanced mds: An updated interim analysis K Saxena, M Konopleva, TD Bhagat, VA Guerra, R Maduike, S Tiziani, ... Blood 136, 31-32, 2020 | 4 | 2020 |
| EXABS-147-AML How Do We Overcome Resistance to Venetoclax K Saxena, BZ Carter, M Konopleva Clinical Lymphoma Myeloma and Leukemia 22, S55-S57, 2022 | 3 | 2022 |
| A 54-year-old man with pancytopenia K Saxena, K Vu, HE Nye JAMA 321 (9), 895-896, 2019 | 3 | 2019 |
| A Short‐Lived Crisis K Saxena, G Dhaliwal, MN Rao, JM Babik Journal of Hospital Medicine 16 (10), 623-627, 2021 | | 2021 |
| Disseminated HPV Following Stem Cell Transplant (SCT) in NK (-) Severe Combined Immune Deficiency (SCID) and Association with NK Cell Dysfunction K Saxena, SK Nicholas, P Banerjee, F Seeborg, T Wright, C Martinez, ... Journal of Allergy and Clinical Immunology 131 (2), AB232, 2013 | | 2013 |
